AiON
← Medical directoryActive ingredient

Febuxostat

A urate-lowering drug. Following the CARES trial, which showed higher all-cause and cardiovascular mortality compared with allopurinol, the AEMPS advises against its use in people who have had a heart attack, stroke or unstable angina unless there is no alternative.

Institutional endorsement by Clínica Evolution

This entry is for information. Your case requires an individual medical assessment.